Effect of high-flow nasal cannula oxygen therapy on exercise capacity in patients with Idiopathic Pulmonary Fibrosis
Not Applicable
- Conditions
- Idiopathic Pulmonary Fibrosis
- Registration Number
- JPRN-UMIN000038945
- Lead Sponsor
- Kobe City Medical Center General Hospital Department of Rehabilitation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 26
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with connective tissue disease, neuromuscular disease or orthopedic problem and other disease which may affect to exercise assessment and requires exercise limitation 2. Patients who have pulmonary hypertension, according to WHO guideline [I-II => NYHA and 25mmHg => mean pulmonary arterial pressure (40mmHg => TRPG)] and use a pulmonary vasodilator 3. Using an anti-arrhythmic drug 4. Using long-term oxygen therapy 5. Patients who cannot be evaluated by 6 minute walk test for any reason 6. Patients who are judged by the investigator as not adequate to participate in this study 7. History of malignant disease within 3 years
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Endurance time of exercise
- Secondary Outcome Measures
Name Time Method 1. Dyspnea (modified Borg Scale) 2. Fatigue of lower limb (modified Borg Scale) 3. Desaturation (SpO2) 4. Heart rate 5. Blood pressure 6. Patient comfort to each device (Visual Analog Scale)